MedPath

CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

88361

Prescription Type

Uso Hospitalario

Authorization Date

Dec 9, 2022

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number88361
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

CABAZITAXELActive
Quantity: 20 mg
Name: CABAZITAXEL

ATC CLASSIFICATION (3)

L01C
L01CD
L01CD04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.